| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
4,108,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
872,448 |
Avg
Vol: |
397,722 |
| 52
Week Range: |
$0.0425 - $0.0425 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile International Stem Cell is a clinical stage biotechnology company focused on therapeutic and biomedical product development. Co. is developing different cell types from its stem cells that may result in therapeutic products. Co.'s subsidiary, Lifeline Skin Care, Inc., develops, manufactures and markets a line of skincare products with anti-aging benefits that is based on Co.'s proprietary human non-embryonic stem cell extract and targeted molecule technologies. Co.'s other subsidiary, Lifeline Cell Technology, LLC, develops, manufactures and commercializes human cell culture products, including frozen human primary cells and the reagents needed to grow, maintain and differentiate the cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Don Wright |
Director |
– • – |
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
99,946 |
746,557 |
|
- |
|
| Maier Paul V |
Director |
– • – |
2015-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
76,958 |
409,736 |
|
- |
|
| Don Wright |
Director |
– • – |
2015-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
76,958 |
646,611 |
|
- |
|
| Semechkin Rouslan |
Chief Scientific Officer |
• • • |
2015-03-31 |
4 |
B |
$0.04 |
$83,388 |
D/D |
1,861,331 |
9,402,715 |
3.23 |
- |
|
| Semechkin Andrei |
Chief Executive Officer |
• • • |
2015-03-31 |
4 |
B |
$0.04 |
$264,061 |
D/D |
5,894,214 |
60,143,521 |
3.23 |
- |
|
| Casamento Charles J |
Director |
– • – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
76,958 |
571,611 |
|
- |
|
| Semechkin Rouslan |
Chief Scientific Officer |
• • • |
2015-02-23 |
4 |
B |
$0.04 |
$83,388 |
D/D |
1,861,331 |
7,541,384 |
3.23 |
- |
|
| Semechkin Andrei |
Chief Executive Officer |
• • • |
2014-12-22 |
4 |
B |
$0.06 |
$339,507 |
D/D |
5,894,214 |
54,249,307 |
3.23 |
- |
|
| Bakalova Sofya |
Dir. Legal Affairs & Operation |
• – – |
2014-10-10 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
40,000 |
2.66 |
- |
|
| Craw John Simon |
Executive Vice President |
• – – |
2014-10-10 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
185,000 |
2.66 |
- |
|
| Novak Tibor Jay |
Chief Financial Officer |
• – – |
2014-10-10 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
40,000 |
2.66 |
- |
|
| Maier Paul V |
Director |
– • – |
2014-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
49,653 |
332,778 |
|
- |
|
| Casamento Charles J |
Director |
– • – |
2014-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
49,653 |
494,653 |
|
- |
|
| Don Wright |
Director |
– • – |
2014-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
49,653 |
569,653 |
|
- |
|
| Bakalova Sofya |
Dir. of Legal Affairs & Oper. |
• – – |
2014-09-26 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
30,000 |
2.66 |
- |
|
| Novak Tibor Jay |
Chief Financial Officer |
• – – |
2014-09-26 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
30,000 |
2.66 |
- |
|
| Craw John Simon |
Executive Vice President |
• – – |
2014-09-26 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
175,000 |
2.66 |
- |
|
| Craw John Simon |
Executive Vice President |
• – – |
2014-09-12 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
165,000 |
2.66 |
- |
|
| Novak Tibor Jay |
Chief Financial Officer |
• – – |
2014-09-12 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
20,000 |
2.66 |
- |
|
| Bakalova Sofya |
Dir. of Legal Affairs & Oper. |
• – – |
2014-09-12 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
20,000 |
2.66 |
- |
|
| Semechkin Andrei |
Chief Executive Officer |
• • • |
2014-09-10 |
4 |
B |
$0.09 |
$350,000 |
D/D |
3,888,889 |
48,355,093 |
3.23 |
- |
|
| Semechkin Rouslan |
Chief Scientific Officer |
• • • |
2014-09-10 |
4 |
B |
$0.09 |
$50,000 |
D/D |
555,556 |
5,680,053 |
3.23 |
- |
|
| Novak Tibor Jay |
Chief Financial Officer |
• – – |
2014-08-29 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
10,000 |
2.66 |
- |
|
| Craw John Simon |
Executive Vice President |
• – – |
2014-08-29 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
155,000 |
2.66 |
- |
|
| Bakalova Sofya |
Dir. of Legal Affairs & Oper. |
• – – |
2014-08-29 |
4 |
B |
$0.10 |
$1,000 |
D/D |
10,000 |
10,000 |
2.66 |
- |
|
108 Records found
|
|
Page 4 of 5 |
|
|
